29 September 2025 in International Journal of Innovative Technologies in Social Science
Objective: Migraine is a common cause of pain in children and adolescents. There has been a consistent rise in the number of diagnoses over the years, which means that the problem is becoming progressively more frequent. The increase in psychiatric diagnoses in children and adolescents, we have raised a question whether there is a connection between these two issues. Methods: Materials and methods An electronic literature search was performed using PubMed. Search terms included “migraine”, “depression”, “anxiety” “bipolar disease”, “obsesive-compulsive disorder”, “anorexia”, “attention deficit hyperactivity disorder”, “insomnia”, “children”, “adolescents”, “psychiatric disorders” as keywords. The review focused on articles published in English and Polish from their inception until 2025. Key Findings: Migraine frequently co-occurs with symptoms of anxiety and depression. A higher incidence of bipolar disorder, OCD, and ADHD has been reported in children with migraine. It is possible that migraine and these conditions share common pathophysiologies. Experiencing chronic pain in childhood is also associated with sleep and eating difficulties, reducing the quality of life of paediatric patients. Conclusion: We present statistics on the co-occurence of these disorders with migraine, as well as reports on the possibility of common pathophysiological substrates and mutual connections, which indicate a significant impact of migraine on the development of mental disorders. However, still more research is needed to obtain valid information on the discovered relationships that would surely help to create more effective and targeted treatment and certainly provide whole-person care for young patients.
16 September 2025 in International Journal of Innovative Technologies in Social Science
Introduction: Systemic sclerosis (SSc) is an autoimmune disease that, because of its heterogeneity, presents clinicians with many therapeutic challenges. The hallmarks of its pathogenesis are vasculopathies, cutaneous or visceral fibrosis and the presence of scleroderma-related antibodies, however, the course of the disease is different in every case. Therefore it is important to adjust the treatment process individually to each patient's needs. In this manuscript we aim to describe options available for therapeutic management of SSc. Materials and methods: An electronic literature search was performed using PubMed, Cochrane Library and Evidence-Based Medicine Reviews. Search terms included “systemic sclerosis”, “methotrexate”, “mycophenolate mofetil” “cyclophosphamide”, “autologous hematopoietic stem cell transplantation”, “tocilizumab”, “nintedanib”, “belimumab”, “rituximab”, “abatacept”, “lenabasum” as keywords. The review focused on articles published in English from their inception until 2025. Conclusions: However, the disease-modifying anti-rheumatic drugs are widely used in systemic sclerosis, currently the biological therapeutics are objects of dynamic researches due to their good benefit-risk ratio. Numerous biological drugs are implemented for alleviating the course of Interstitial Lung Disease as it remains main cause of death among SSc patients. Additionally, some clinical manifestations of SSc, including Raynaud phenomenon (RP) and Pulmonary Artery Hypertension (PAH) are treating rather symptomatically then causatively. We hope our manuscript contributed to better understanding of therapeutic approaches of systemic sclerosis.
6 January 2026 in International Journal of Innovative Technologies in Social Science
Introduction and purpose: Ulcerative colitis (UC) is one of the subtypes of inflammatory bowel disease (IBD), alongside Crohn’s disease. UC is associated with an inflammatory process occurring in the mucosa and submucosa of the large intestine. Various factors interact in the pathogenesis, determining the development and progression of UC. These include genetic and environmental factors, as well as changes in the immune system. The role of oxidative stress is also emphasized. Serum selenium (Se) levels in patients with UC were lower than in healthy individuals. Furthermore, the level of this microelement was inversely correlated with disease activity. In this paper, we review the physiological roles of Se and its impact on the course of UC. Given the multifaceted role of this microelement in the human body, we primarily focus on the influence of Se as a dietary component on immune response mechanisms and inflammation. Materials and methods: A systematic literature search was conducted using the electronic databases, including PubMed and Google Scholar. Various combinations of the following keywords were used in the search „ulcerative colitis”, „selenium”, „oxidative stress” and „ulcerative colitis pathophysiology”. The search was limited to publications from the last 5 years. Those directly related to the topic under discussion were then selected. Conclusions: Studies confirm the beneficial effect of Se on the course of UC. They present the mechanisms underlying the anti-inflammatory action of Se, from molecular processes at the gene expression level to clinical evidence demonstrating improved quality of life. The effects of Se supplementation appear promising, but further research in this area in needed.
29 September 2025 in International Journal of Innovative Technologies in Social Science
Introduction: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed neurodevelopmental disorders in children and adolescents. Various treatment methods are available for this condition, including pharmacological and non-pharmacological strategies. Pharmacotherapy is currently the most effective method of reducing the core symptoms of ADHD. The most commonly used medications include psychostimulants such as methylphenidate and amphetamines. Comparing the efficacy and safety of available medications is particularly important in order to select the appropriate treatment for individual. Aim of the study: The aim of our study is to review the available literature on the pharmacological treatment of attention deficit hyperactivity disorder and to summarize current knowledge. We presented the mechanisms of action, clinical efficacy, and safety profile of individual drugs used in the pharmacotherapy of ADHD. Methods and materials: We reviewed the literature available in the PubMed database using the following keywords: “ADHD treatment”; “Attention Deficit Hyperactivity Disorder treatment”; “Stimulants”; “Non-stimulants”; “Methylphenidate”; “Atomoxetine”; “ADHD”; “Bupropion”; ‘Modafinil’; “α-agonists”; “Lisdexamphetamine (LDX)”; “Mixed Amphetamine Salts”, “Clonidine”; “Viloxazine”; “Centanafadine” Conclusion: Pharmacotherapy is the most effective method of reducing the core symptoms of ADHD. Psychostimulants are currently considered the most effective and most commonly used drugs for the treatment of attention deficit hyperactivity disorder. In cases of intolerance or contraindications to their use, non-stimulant medications are an alternative. New medications such as viloxazine and centanafadine also offer promising alternatives. Individualization of pharmacological treatment is crucial to achieve optimal results.